Dr. El Hajjar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
201 E University Parkway
Dept of Internal Medicine
Baltimore, MD 21218Phone+1 410-554-2284Fax+1 410-554-2184
Education & Training
- University of Balamand Faculty of MedicineClass of 2020
Publications & Presentations
PubMed
- 1 citationsThe convergence of tumor suppressors on the type I interferon pathway in clear cell renal cell carcinoma and its therapeutic implications.Lauren E Langbein, Rayan El Hajjar, William Y Kim, Haifeng Yang
American Journal of Physiology. Cell Physiology. 2022-11-01 - 9 citationsBAP1 maintains HIF-dependent interferon beta induction to suppress tumor growth in clear cell renal cell carcinoma.Lauren E Langbein, Rayan El Hajjar, Shen He, Eleonora Sementino, Zhijiu Zhong
Cancer Letters. 2022-10-28 - 5 citationsCarbapenemase Inhibitors: Updates on Developments in 2021.Maroun Bou Zerdan, Sally Al Hassan, Waleed Shaker, Rayan El Hajjar, Sabine Allam
Journal of Clinical Medicine Research. 2022-07-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: